Used in research settings to quantify the concentration of plasmin-anti-plasmin complexes in biological samples, this ELISA kit serves as a valuable tool in studying fibrinolysis and coagulation processes. It enables researchers to assess the activation of plasminogen and the body’s regulation of clot breakdown, which is critical in understanding thrombotic disorders, liver disease, and conditions involving abnormal fibrinolysis. The assay is commonly applied in clinical research to evaluate the status of the hemostatic system, monitor disease progression, and investigate the effectiveness of anticoagulant or fibrinolytic therapies. Due to its specificity, it supports studies focused on cardiovascular diseases, sepsis, and cancer, where dysregulation of proteolytic systems plays a role.